ATRA vs MA · rev $128.9M vs P/E 38, rev $32.79B
Atara Biotherapeutics Inc (ATRA) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
ATRA currently screens at market cap $87.1M. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the ATRA and MA stock pages for the full models.
Not investment advice.